Anticoagulant therapy in patients with congenital FXI deficiency

The bleeding phenotype of factor XI (FXI) deficiency is unpredictable. Bleeding is usually mild and mostly occurs after injury. Although FXI deficiency renders antithrombotic protection, some patients might eventually develop thrombosis or atrial fibrillation, requiring anticoagulant therapy. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravo-Pérez, Carlos, Serna, María Jose, Esteban, Julio, Fernandez-Mellid, Eugenia, Fontanes-Trabazo, Emilia, Lorenzo, Alvaro, Calviño-Suárez, Michael, Miñano, Antonia, Padilla, José, Roldán, Vanessa, Vicente, Vicente, Corral, Javier, de la Morena-Barrio, María Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945614/
https://www.ncbi.nlm.nih.gov/pubmed/34597376
http://dx.doi.org/10.1182/bloodadvances.2021005695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945614/
https://www.ncbi.nlm.nih.gov/pubmed/34597376
http://dx.doi.org/10.1182/bloodadvances.2021005695

Ejemplares similares